Frequently Asked Questions

We focus on Series A through growth equity rounds, typically investing $10M-$100M per company. We look for companies with $5M+ revenue and 50%+ YoY growth. Our ideal companies have achieved product-market fit and are ready to scale.

We invest in nutrition companies across several focus areas:

• B12 & Cellular Health: Plant-based B12 alternatives, precision fermentation, bioavailability optimization
• Herbal & Botanical: Adaptogenic herbs, standardized extracts, clinically-backed botanical products
• Targeted Nutrition: Specialized supplements for cognitive support, immune function, metabolic health
• Wellness Platforms: Integrated nutrition solutions and personalized supplementation ecosystems

Our typical timeline is:

• Initial screening: 2 weeks for investment thesis fit assessment
• Management meetings: 2-3 meetings over 4-8 weeks
• Due diligence: 6-8 weeks for comprehensive financial, technical, and regulatory review
• Closing: 30-60 days post-LOI

Total process typically 4-6 months from initial meeting to closing.

We look for companies with gross margins of 60%+ as a baseline. For premium, clinical-backed products or companies with direct-to-consumer channels, we often see margins of 70-80%+. Margins are a critical indicator of unit economics and pricing power.

Yes, we typically take board representation in our investments. Beyond financial capital, we provide strategic guidance on market expansion, supply chain optimization, go-to-market strategy, and operational scaling. Our team brings decades of nutrition industry expertise.

We provide comprehensive strategic support including:

• Supply chain optimization and ingredient sourcing guidance
• Regulatory strategy and compliance support
• Go-to-market acceleration and distribution partnerships
• Access to our network of strategic buyers, investors, and industry experts
• M&A advisory if you consider exit opportunities

We target exits within 5-7 years through:

• Strategic acquisition by major CPG, pharma, or nutraceutical players (most common)
• Secondary sale to other financial investors or platform consolidators
• IPO for high-growth, market-leading companies

Our historical average return is 8.5x MOIC across our portfolio.

To start the process:

1. Schedule a confidential consultation using the form on our website
2. Prepare a company overview, financials, and growth metrics
3. Have an initial screening meeting with our team (30 minutes)
4. If there's fit, we'll schedule deeper management meetings

Contact us at info@anchornutritioninvestmentbank.com or call +1 (833) 834-5580 to begin the conversation.

Yes, we typically participate in follow-on rounds to support successful portfolio companies. If your company achieves growth milestones and validates product-market fit, we'll often lead or participate in your next funding round.

We primarily invest in US-based companies but have experience with companies operating across North America and internationally. We focus on companies with strong US market presence and growth potential. International operations are a plus if the company has significant revenue diversification.